Wave Life Sciences WVE Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -56.2%— | —— | —— | —— | |
| Return on assets | -41.3%— | —— | -27.3%+64.3pp | -91.6%-41.3pp | |
| Liquidity | |||||
| Current ratio | 6.5×+3.6× | 2.9×+1.6× | 1.3×-0.1× | 1.4×-1.2× | |
| Quick ratio | 6.5×+3.6× | 2.9×+1.6× | 1.3×-0.1× | 1.4×-1.2× | |
| Cash ratio | 6.3×+3.6× | 2.7×+1.6× | 1.1×-0.2× | 1.2×-1.1× | |
| Leverage | |||||
| Debt-to-equity | 0×-0.1× | 0.1×-0.7× | 0.8×— | —— | |
| Debt-to-assets | 0×0.0× | 0.1×0.0× | 0.1×-0.1× | 0.3×+0.1× | |
| Per Share | |||||
| Book value per share | $3.07+103% | $1.52+306% | $0.37+165% | -$0.57-191% | |
| Valuation | |||||
| Market capitalization | $1.14B+9.2% | $1.89B+241% | $553.62M-9.0% | $608.37M+229% | |
| Enterprise value | $615.92M-27.2% | $1.61B+318% | $385.39M-30.9% | $557.48M+770% | |
| Price / book | 2.2×-3.7× | 9×-5.0× | 14×— | —— | |
| Free cash flow yield | -16.7%+1.2pp | -8.1%— | —— | -21.2%+27.2pp | |
| Earnings yield | -16.6%— | —— | -10.4%+16.2pp | -26.6%+39.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Wave Life Sciences's ratios come from?
- Every ratio is computed from Wave Life Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
